Pharmacologic considerations in the treatment of depression
Mejía Rivera, L.C.
Boletin de la Asociacion Medica de Puerto Rico 100(3): 36
2008
ISSN/ISBN: 0004-4849 PMID: 19227715 Document Number: 702551
Document emailed within 1 workday
Related Documents
Ereshefsky, L. 1999: Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic Journal of Clinical Psychiatry 60(Suppl 10): 20-30Hassan, T. 1987: Pharmacologic considerations for patients taking oral contraceptives Connecticut Dental Student Journal 7: 7-8
Ireland, R.R. 2002: Pharmacologic considerations for serotonin reuptake inhibitor use by aviators Aviation Space and Environmental Medicine 73(5): 421-429
Invernizzi, G.; Sostero, M.; Vitali, A.; Campanella, F. 1971: Pharmacologic combinations in the therapy of depression: experiences with Mutabon (perphenazine and amitriptyline) Rivista Sperimentale di Freniatria e Medicina Legale Delle Alienazioni Mentali 95(6): 1143-1181
Frank, E.; Perel, J.M.; Mallinger, A.G.; Thase, M.E.; Kupfer, D.J. 1992: Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression Psychopharmacology Bulletin 28(3): 231-235
Penn, G.M. 1978: Some considerations. Depression and the healing process Journal of the Kansas Medical Society 79(11): 598-600,604
Krause, R. 1994: Loss, grief and depression: considerations based on emotion research Zeitschrift für Psychosomatische Medizin und Psychoanalyse 40(4): 324-330
Scott, A.I. 1997: Treatment of postnatal depression. Two weeks of depression may not be long enough to exclude spontaneous recovery Bmj 315(7100): 122
Grand, E. 1994: Decubitus ulcer as a symptom of depression. the prognosis is dependent on the form of depression and on its treatment Pflege Zeitschrift 47(10): 544-547
Costa, F.V. 1988: Clinical pharmacologic aspects of mepartricin. Possible pharmacologic interference with digitaloids and anticoagulants Minerva Urologica e Nefrologica 40(2 Suppl): 5-6
Sleptsova, S.I. 1987: Effects of various pharmacologic and non-pharmacologic agents on the mother and fetus (data for the health promotion propaganda) Akusherstvo i Ginekologiia 12: 68-71
Zimmerman, M.; Chelminski, I.; Posternak, M. 2004: A review of studies of the Hamilton depression rating scale in healthy controls: implications for the definition of remission in treatment studies of depression Journal of Nervous and Mental Disease 192(9): 595-601
Dowrick, C.; Dunn, G.; Ayuso-Mateos, J.L.; Dalgard, O.S.; Page, H.; Lehtinen, V.; Casey, P.; Wilkinson, C.; Vazquez-Barquero, J.L.; Wilkinson, G. 2000: Problem solving treatment and group psychoeducation for depression: multicentre randomised controlled trial. Outcomes of Depression International Network (ODIN) Group Bmj 321(7274): 1450-1454
Lee, Y.; Lin, P-Yen.; Hsu, S-Ting.; Cing-Chi, Y.; Yang, L-Cheng.; Wen, J-Kwang. 2008: Comparing the use of the Taiwanese Depression Questionnaire and Beck Depression Inventory for screening depression in patients with chronic pain Chang Gung Medical Journal 31(4): 369-377
Honorato Pérez, J.; Azanza Perea, J.R.; Cuena Boy, R. 1984: Pharmacologic treatment of ulcers Revista de Medicina de la Universidad de Navarra 28(2): 53-58
Pinals, R.S. 1992: Pharmacologic treatment of osteoarthritis Clinical Therapeutics 14(3): 336-46; Discussion 335
Felder, M. 1998: Pharmacologic pain treatment Praxis 87(9): 295-299
De Montigny, P.; Clerc, C.; Descarpentries, C. 2006: Pharmacologic treatment of diabetes Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 4(2): 30-34
Bannwarth, B. 2003: Antalgic, pharmacologic and non-pharmacologic treatments La Revue du Praticien 53(16): 1819-1826
Wolfersdorf, M.; Stieglitz, R.D.; Metzger, R.; Ruppe, A.; Stabenow, S.; Hornstein, C.; Keller, F.; Schell, G.; Berger, M. 1997: Quality assurance in inpatient treatment of depression. Aspects of quality monitoring and external quality assurance exemplified by a pilot project of inpatient treatment of depression Psychiatrische Praxis 24(3): 120-128